Meomel

Meloxicam, the active ingredient in Meomel, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients.

GNH USA supplies Meomel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. With a focus on regulatory compliance, GNH USA ensures product integrity throughout the supply chain, supporting healthcare providers in delivering effective therapies to patients.

Meloxicam is used in the musculoskeletal and inflammatory disease spectrum to reduce pain and inflammation. - Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: alleviates inflammatory joint pain and slows disease progression in adult patients. - Ankylosing spondylitis: diminishes spinal inflammation and associated discomfort in affected individuals. - Acute pain: provides short‑term relief of moderate to severe pain from various causes.

Meloxicam may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain or heartburn that may affect daily activities. - Headache: mild to moderate intensity, often transient but may require analgesic management. - Peripheral edema: swelling of the lower limbs, occasionally accompanied by mild weight gain. Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: can present as black stools, vomiting blood or severe abdominal pain. - Cardiovascular events: increased risk of myocardial infarction, stroke or hypertension, particularly with long‑term use. - Severe hepatic injury: jaundice, elevated liver enzymes or hepatic failure requiring medical attention.

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risks. - Assess gastrointestinal risk: evaluate history of ulcers, bleeding or concurrent NSAID use. - Monitor renal function: check serum creatinine and urine output, especially in elderly or dehydrated patients. - Evaluate cardiovascular status: avoid in patients with uncontrolled hypertension or recent cardiac events. - Use lowest effective dose: prescribe the minimal dose needed for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions such as rash or bronchospasm occur. - Store at ambient temperature: keep tablets in the original container, protect from moisture and heat.

Meloxicam can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: potential for decreased kidney perfusion and electrolyte imbalance. - Methotrexate: reduced clearance leading to toxicity.